| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 993 | 2022 |
| Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services AY Liu, SE Cohen, E Vittinghoff, PL Anderson, S Doblecki-Lewis, O Bacon, ... JAMA internal medicine 176 (1), 75-84, 2016 | 675 | 2016 |
| Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase HM El Sahly, LR Baden, B Essink, S Doblecki-Lewis, JM Martin, ... New England Journal of Medicine 385 (19), 1774-1785, 2021 | 547 | 2021 |
| High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project SE Cohen, E Vittinghoff, O Bacon, S Doblecki-Lewis, BS Postle, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (4), 439-448, 2015 | 226 | 2015 |
| A cost analysis of hospitalizations for infections related to injection drug use at a county safety-net hospital in Miami, Florida H Tookes, C Diaz, H Li, R Khalid, S Doblecki-Lewis PloS one 10 (6), e0129360, 2015 | 134 | 2015 |
| Bacterial and viral co-infections complicating severe influenza: incidence and impact among 507 US patients, 2013–14 NS Shah, JA Greenberg, MC McNulty, KS Gregg, J Riddell IV, ... Journal of clinical virology 80, 12-19, 2016 | 117 | 2016 |
| Risk factors for recurrent lower extremity cellulitis in a US Veterans Medical Center population SD Lewis, GS Peter, O Gomez-Marin, AL Bisno The American journal of the medical sciences 332 (6), 304-307, 2006 | 81 | 2006 |
| Healthcare access and PrEP continuation in San Francisco and Miami after the US PrEP demo project S Doblecki-Lewis, A Liu, D Feaster, SE Cohen, G Cardenas, O Bacon, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 74 (5), 531-538, 2017 | 79 | 2017 |
| Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results … O Ogbuagu, PJ Ruane, D Podzamczer, LC Salazar, K Henry, DM Asmuth, ... The Lancet HIV 8 (7), e397-e407, 2021 | 75 | 2021 |
| Severe influenza in 33 US hospitals, 2013–2014: complications and risk factors for death in 507 patients NS Shah, JA Greenberg, MC McNulty, KS Gregg, J Riddell, JE Mangino, ... infection control & hospital epidemiology 36 (11), 1251-1260, 2015 | 65 | 2015 |
| Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod L Abbo, V Vincek, G Dickinson, N Shrestha, S Doblecki, PAJ Haslett Clinical infectious diseases 44 (3), e25-e27, 2007 | 62 | 2007 |
| Medical complications in physical medicine and rehabilitation DD Cardenas, TM Hooton Demos Medical Publishing, 2014 | 57 | 2014 |
| Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin P Lichtenberger, I Rosa‐Cunha, M Morris, S Nishida, E Akpinar, J Gaitan, ... Transplant Infectious Disease 11 (2), 137-142, 2009 | 49 | 2009 |
| Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature AP Garrison, MI Morris, S Doblecki Lewis, L Smith, TJ Cleary, GW Procop, ... Transplant infectious disease 11 (6), 541-548, 2009 | 47 | 2009 |
| Changes in kidney function associated with daily tenofovir disoproxil fumarate/emtricitabine for HIV preexposure prophylaxis use in the United States demonstration project EC Tang, E Vittinghoff, PL Anderson, SE Cohen, S Doblecki-Lewis, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 77 (2), 193-198, 2018 | 45 | 2018 |
| A randomized study of passive versus active PrEP patient navigation for a heterogeneous population at risk for HIV in South Florida S Doblecki-Lewis, S Butts, V Botero, K Klose, G Cardenas, D Feaster Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2019 | 37 | 2019 |
| Community federally qualified health centers as homes for HIV preexposure prophylaxis: perspectives from South Florida S Doblecki-Lewis, D Jones Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2016 | 35 | 2016 |
| Effects of Tocilizumab in COVID-19 patients: a cohort study CA Vu, KJ DeRonde, AD Vega, M Maxam, G Holt, Y Natori, JG Zamora, ... BMC infectious diseases 20, 1-10, 2020 | 33 | 2020 |
| Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida Y Jo, TS Bartholomew, S Doblecki-Lewis, A Rodriguez, DW Forrest, ... PloS one 15 (4), e0231424, 2020 | 33 | 2020 |
| Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis EC Tang, E Vittinghoff, SS Philip, S Doblecki-Lewis, O Bacon, W Chege, ... Aids 34 (8), 1181-1186, 2020 | 29 | 2020 |
